2009
DOI: 10.1089/aid.2009.0140
|View full text |Cite
|
Sign up to set email alerts
|

Near Full-Length Genome Characterization of a Newly Identified HIV Type 1 Subtype F Variant Circulating in St. Petersburg, Russia

Abstract: We report the near full-length genome characterization of an HIV-1 subtype F virus (D88_845) collected in St. Petersburg, Russia, from a 25-year-old Russian woman perinatally infected in 1982. In a Bayesian phylogenetic analysis, the genome sequence branched basally to the subsubtype F1 clade. In partial sequences, D88_845 clustered with 13 other subtype F sequences from Russia, corresponding to gag (n = 2), pol (n = 3), and env (n = 8) segments. At least 11 of these sequences are from samples collected in St.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
5
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 17 publications
0
5
0
Order By: Relevance
“…Donor samples were collected between 2009 and 2011, and included a mix of supernatants obtained from recently infected (Fiebig IV and V) and chronically infected individuals as defined by the contributing laboratory. Thirty-three viral supernatants were obtained from the Centre for AIDS Reagents, NIBSC HPA UK, supported by the EC FP6/7 Europrise Network of Excellence, and NGIN consortia and the Bill and Melinda Gates GHRCCAVD Project and were donated by Lucia Pérez Alvarez (Instituto de Salud Carlos III) (Fernandez-Garcia et al, 2009; Cuevas et al, 2010; Fernandez-Garcia et al, 2010; Delgado et al, 2012; Thomson et al, 2012; Diez-Fuertes et al, 2013). Twenty-three culture supernatants from donors in Cameroon, Spain, USA and Germany were kindly provided by Indira Hewlett (CBER, FDA) (Vallejo et al, 2003; Ragupathy et al, 2011; Zhao et al, 2012).…”
Section: Methodsmentioning
confidence: 99%
“…Donor samples were collected between 2009 and 2011, and included a mix of supernatants obtained from recently infected (Fiebig IV and V) and chronically infected individuals as defined by the contributing laboratory. Thirty-three viral supernatants were obtained from the Centre for AIDS Reagents, NIBSC HPA UK, supported by the EC FP6/7 Europrise Network of Excellence, and NGIN consortia and the Bill and Melinda Gates GHRCCAVD Project and were donated by Lucia Pérez Alvarez (Instituto de Salud Carlos III) (Fernandez-Garcia et al, 2009; Cuevas et al, 2010; Fernandez-Garcia et al, 2010; Delgado et al, 2012; Thomson et al, 2012; Diez-Fuertes et al, 2013). Twenty-three culture supernatants from donors in Cameroon, Spain, USA and Germany were kindly provided by Indira Hewlett (CBER, FDA) (Vallejo et al, 2003; Ragupathy et al, 2011; Zhao et al, 2012).…”
Section: Methodsmentioning
confidence: 99%
“…Pure clade E has never been isolated but rather appears as an A/E mosaic which has been detected in Thailand, the Philippines, China and Central Africa [14,15]. Subtype F has been reported in Central Africa [17,18], South America [19] and Eastern Europe [20,21] while G and A/G recombinants have been observed in Western and Eastern Africa as well as in central Europe [15]. Subtypes H and J were described in Central Africa [22,23,24]) and in Angola [25,26]).…”
Section: Introductionmentioning
confidence: 99%
“…[2][3][4] In 1995-1996 HIV-1 infections began to increase dramatically concomitantly with the expansion of a subtype A variant of Central African ancestry 5 that originated in Southern Ukraine 6,7 and spread to all countries of the former Soviet Union (FSU), in most of which it is the predominant HIV-1 genetic form 8,9 ; for this reason it is frequently designated A FSU variant. In addition to A FSU , other HIV-1 genetic forms circulating in FSU countries at lower prevalences include subtype B, predominant in men who have sex with men, [8][9][10] CRF03_AB, predominant in the Russian cities of Kaliningrad 11 and Cherepovets, 12 subtype F, circulating as a minor variant in St. Petersburg, Russia, 13 and a CRF02_AG variant (CRF02_AG FSU ), 14,15 which was first detected among injecting drug users (IDUs) in Tashkent, Uzbekistan, in 1999-2000, 14 and has subsequently been reported in Kazakhstan, new near full-length genome sequences of CRF63_02A1, reanalyzing its mosaic structure, and we estimate its epidemic history. For this study, 26 serum samples from HIV-1-infected individuals were collected in May and June 2013 at the Center for Prevention and Control of AIDS and Infectious Diseases, Koltsovo, Novosibirsk region, which is located 5 km from the city of Novosibirsk and attends all HIV-infected people of the Novosibirsk region.…”
mentioning
confidence: 99%